Kev piav qhia
Palbociclib intermediate 2-amino-5-bromopyridine CAS 1072-97-5Qhov zoo tshaj plaws nruab nrab cov ntsiab lus no yog ib qho tseem ceeb ntawm cov synthesis ntawm palbociclib, lub zog thiab xaiv cyclin-dependent kinase 4 thiab 6 inhibitor.Cov mis mos molecular ntawm qhov nruab nrab no yog C5H5BrN2 thiab qhov hnyav molecular yog 173.01.Nws yog siv nyob rau hauv zus tau tej cov Palbociclib, ib tug tseem ceeb tshuaj tiv thaiv mob cancer ntawm lub mis.
Palbociclib, tseem paub los ntawm nws lub npe lag luam Ibrance, tau lees paub dav dav rau nws cov txiaj ntsig hauv kev kho cov tshuaj hormone receptor-zoo thiab HER2-negative advanced lossis metastatic mis mob cancer.Raws li cov khoom tseem ceeb hauv cov txheej txheem tsim khoom palbociclib, peb 2-amino-5-bromopyridine intermediate yog cov khoom tseem ceeb hauv kev lag luam kws tshuaj.Nws cov purity siab thiab meej tshuaj muaj pes tsawg leeg ua rau nws yog ib qho tseem ceeb muaj nyob rau hauv zus tau tej cov tshuaj cawm txoj sia.
Xaiv Peb
JDK muaj cov chaw tsim khoom thawj zaug thiab cov cuab yeej tswj kev ua haujlwm zoo, uas ua kom muaj kev ruaj khov ntawm API intermediates.Pab neeg tshaj lij paub tseeb R & D ntawm cov khoom.Tawm tsam ob qho tib si, peb tab tom nrhiav rau CMO & CDMO hauv kev lag luam hauv tsev thiab thoob ntiaj teb.
